Aside from fat loss, my guess is that what we'll ultimately find is that the benefits of GLP-1 therapy are primarily due to reduced blood sugar and/or ketosis, either/both of which (along with fat loss) could contribute to improved mitochondrial health and lower chronic inflammation. That could in turn improve all sorts of symptoms, not least of which would be migraine and depression.